Characterizing a Clinical Trial - Representative, Real-World Population with Heart Failure with Reduced Ejection Fraction

被引：1

作者：

Wells, Quinn S. ^{[1
,2
]}

Farber-Eger, Eric ^{[1
,2
]}

Lipworth, Loren ^{[2
,3
]}

Dluzniewski, Paul ^{[4
]}

Dent, Ricardo ^{[4
]}

Umeijiego, John ^{[4
]}

Cohen, Sarah S. ^{[3
,5
]}

机构：

[1] Vanderbilt Univ, Dept Med, Div Cardiovasc Med, Med Ctr, Nashville, TN USA

[2] Vanderbilt Univ, Med Ctr, Vanderbilt Translat & Clin Cardiovasc Res Ctr VTR, Nashville, TN USA

[3] Vanderbilt Univ, Dept Med, Div Epidemiol, Med Ctr, Nashville, TN 37235 USA

[4] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA 91320 USA

[5] Toxstrategies Inc, Epidstrategies, Cary, NC 27511 USA

来源：

CLINICAL EPIDEMIOLOGY | 2022年 / 14卷

关键词：

heart failure; reduced ejection fraction; real-world evidence; electronic health record; RANDOMIZED INTERVENTION TRIAL; CIBIS-II; MORTALITY; ENALAPRIL; SURVIVAL; METOPROLOL; MORBIDITY; OUTCOMES;

D O I：

10.2147/CLEP.S341919

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

li li li Conclusion: Approximately 40% of RW HFrEF patients met criteria for the GALACTICHF trial. While findings of ongoing clinical trials may be directly generalizable to this sizable proportion of patients, future trials should examine whether the majority of patients with lower prevalence of comorbidities and rate of HF hospitalization could benefit from emerging HF treatments.

引用

页码：39 / 49

页数：11

共 50 条

[21] Analysis of Physician Compliance with Guideline-Directed Medical Therapy for Patients with Heart Failure with Reduced Ejection Fraction: A Real-World Study
Wang, Guixia
Liu, Liming
Wang, Xiaobo
Yu, Ting
Xu, Hui
Zhang, Tingjun
Lin, Jiafu
Luo, Hao
Liu, Yanxu
Jiang, Lanxiang
Hu, Wenlong
Hu, Houxiang
REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (09)
[22] Early and rapid initiation of quadruple therapy for heart failure with reduced ejection fraction: A real-world experience
Sze, Shirley
Thaitirarot, Chokanan
Krishnan, Sunanthiny
Chan, Daniel
Nicolsona, Will
Squire, Iain
Clayton, Louise
Lokeb, Ian
CLINICAL MEDICINE, 2025, 25 (02)
[23] Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized With Heart Failure and Reduced Ejection Fraction
Fudim, Marat
Sayeed, Sabina
Xu, Haolin
Matsouaka, Roland A.
Heidenreich, Paul A.
Velazquez, Eric J.
Yancy, Clyde W.
Fonarow, Gregg C.
Hernandez, Adrian F.
DeVore, Adam D.
CIRCULATION-HEART FAILURE, 2020, 13 (04)
[24] The Characteristics and Outcomes of Patients with Heart Failure and Reduced Ejection Fraction: The Eligibility of Novel Heart Failure Medications
Fong, Man-Cai
Chang, Hung-Yu
Wang, Chun-Chieh
Feng, An-Ning
Lin, Wei-Shiang
Wu, Yen-Wen
Sung, Shih-Hsien
Huang, Jin-Long
Kuo, Jen-Yuan
Yin, Wei-Hsian
ACTA CARDIOLOGICA SINICA, 2021, 37 (04) : 394 - 403
[25] Neprilysin Inhibition in Heart Failure with Reduced Ejection Fraction: A Clinical Review
King, Jordan B.
Bress, Adam P.
Reese, Austin D.
Munger, Mark A.
PHARMACOTHERAPY, 2015, 35 (09): : 823 - 837
[26] Management of heart failure with reduced ejection fraction
Haydock, Paul M.
Flett, Andrew S.
HEART, 2022, 108 (19) : 1571 - 1579
[27] Sex differences in the generalizability of randomized clinical trials in heart failure with reduced ejection fraction
Schroeder, Megan
Lim, Yvonne Mei Fong
Savarese, Gianluigi
Suzart-Woischnik, Kiliana
Baudier, Claire
Dyszynski, Tomasz
Vaartjes, Ilonca
Eijkemans, Marinus J. C.
Uijl, Alicia
Herrera, Ronald
Vradi, Eleni
Brugts, Jasper J.
Brunner-La Rocca, Hans-Peter
Blanc-Guillemaud, Vanessa
Waechter, Sandra
Couvelard, Fabrice
Tyl, Benoit
Fatoba, Samuel
Hoes, Arno W.
Lund, Lars H.
Gerlinger, Christoph
Asselbergs, Folkert W.
Grobbee, Diederick E.
Cronin, Maureen
Koudstaal, Stefan
EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (06) : 912 - 921
[28] Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
Greene, Stephen J.
Fonarow, Gregg C.
DeVore, Adam D.
Sharma, Puza P.
Vaduganathan, Muthiah
Albert, Nancy M.
Duffy, Carol, I
Hill, Larry
McCague, Kevin
Patterson, J. Herbert
Spertus, John A.
Thomas, Laine
Williams, Fredonia B.
Hernandez, Adrian F.
Butler, Javed
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (19) : 2365 - 2383
[29] Pharmacological treatment options for heart failure with reduced ejection fraction: A 2022 update
Hellenkamp, Kristian
Nolte, Kathleen
von Haehling, Stephan
EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (06) : 673 - 680
[30] Accelerated and personalized therapy for heart failure with reduced ejection fraction
Shen, Li
Jhund, Pardeep Singh
Docherty, Kieran Francis
Vaduganathan, Muthiah
Petrie, Mark Colquhoun
Desai, Akshay Suvas
Kober, Lars
Schou, Morten
Packer, Milton
Solomon, Scott David
Zhang, Xingwei
McMurray, John Joseph Valentine
EUROPEAN HEART JOURNAL, 2022, 43 (27) : 2573 - 2587

← 1 2 3 4 5 →